Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q15075
UPID:
EEA1_HUMAN
Alternative names:
Endosome-associated protein p162; Zinc finger FYVE domain-containing protein 2
Alternative UPACC:
Q15075; Q14221
Background:
Early endosome antigen 1, also known as Endosome-associated protein p162 and Zinc finger FYVE domain-containing protein 2, plays a crucial role in cellular processes by binding phospholipid vesicles containing phosphatidylinositol 3-phosphate. This action is vital for endosomal trafficking, facilitating the transport and sorting of molecules within the cell.
Therapeutic significance:
Understanding the role of Early endosome antigen 1 could open doors to potential therapeutic strategies. Its involvement in endosomal trafficking highlights its importance in cellular function and disease mechanisms.